Turn this role into an interview — a resume and cover letter built around what this employer wants.
Octapharma Vienna is seeking a Group Expert QC Innovation for Operations (m/f/d) in a temporary capacity. The role focuses on coordinating analytical activities, technology transfers, and continuous improvements within Group QC, collaborating across QC, R&D, and Method Validation.
Strong analytical background and project leadership are essential. The position is based in Vienna, starting ASAP and running until 30.04.2027, with clear links to cross-functional teams and global QC collaboration.
Select how often (in days) to receive an alert:
Job ID: 63975
Location: Wien, AT
Job Level: Entry Level
Job Category: Quality
Employment Type: Temporary employment
Become part of a vital chain and contribute to our common goal of making people’s lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
With over 1700 employees, the Octapharma site in Vienna is the largest production site, and successful research and development location.
As a Group Expert QCIO, you will play a key role representing Group Quality Control (QC) in projects involving new pipeline products, the optimization of licensed products, technology transfers and continuous improvements. Working closely with stakeholders from QC, R&D and Method Validation, you will coordinate critical analytical activities and ensure successful collaboration across functions and sites. This position is ideal for someone with a strong analytical background who enjoys leading projects, building relationships and bringing people together to achieve common goals.
This is a temporary position based in Vienna, starting as soon as possible and running until 30.04.2027.
Join us in shaping our vision of providing new health solutions advancing human life.
Master's degree or Ph.D. in Chemistry, Biochemistry, Analytical Chemistry or a related scientific discipline
Experience with analytical methods and method validation in a GMP-regulated environment
Strong communication and stakeholder management skills, with the ability to collaborate effectively across functions and sites
"What I appreciate most about leading this team is the combination of a collaborative atmosphere and the opportunity to make a real impact across our global organisation. Although we are a relatively small team, we work closely with colleagues, experts and stakeholders across multiple sites and functions. As Group Expert QCIO, you will play a key role in supporting Octapharma’s analytical development, validation and technology transfer activities, helping ensure that our global Quality Control organisation can meet both current and future business needs. If you enjoy bringing people together, driving projects forward and building strong collaborations, this is a fantastic opportunity to make a difference." — Barbara Malkowsky, Group Head QC Method Validation and Analytical Lifecycle
Enjoy these attractive benefits! You can find all offers here: Benefits The minimum gross salary according to the collective agreement (chemical industry) is EUR 4,355.55 based on 38 hours per week (full-time). As we strive to offer a salary that reflects your individual profile and qualifications, there is a willingness to pay above the minimum salary.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care.
With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 200 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.